Title IX is a spending clause type of legislation, which gives the federal government enforcement power by giving grants to ...

Evolutionary genetics is the study of how genetic variation ... Mice models often fail to reflect human telomere biology. Here, the authors engineer a mouse strain with a humanized mTert gene ...

Q1 2025 Earnings Call Transcript February 10, 2025 Arrowhead Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-1.39 EPS, expectations were $-0.42. Chris Anzalone: Thanks, Vince.

Arrowhead Pharmaceuticals (NASDAQ:ARWR) reported a larger-than-expected loss for Q1 FY2025, with earnings per share (EPS) at -$1.39, missing the forecast of -$0.39. Revenue also fell short, totaling ...